Michaeline Hebron

3.4k total citations · 1 hit paper
47 papers, 2.5k citations indexed

About

Michaeline Hebron is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michaeline Hebron has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 16 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michaeline Hebron's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (13 papers) and Autophagy in Disease and Therapy (12 papers). Michaeline Hebron is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (13 papers) and Autophagy in Disease and Therapy (12 papers). Michaeline Hebron collaborates with scholars based in United States, China and South Korea. Michaeline Hebron's co-authors include Charbel Moussa, Irina Lonskaya, Jaeil Ahn, Raymond Scott Turner, Xu Huang, Paul Aisen, Robert A. Rissman, Norah K. Algarzae, Xiaoguang Liu and Yasar Torres‐Yaghi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michaeline Hebron

46 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

2017 568 citations Charbel Moussa, Michaeline Hebron et al. Journal of Neuroinflammation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michaeline Hebron United States	25	886	847	837	549	490	47	2.5k
Charbel Moussa United States	36	1.5k 1.7×	1.5k 1.7×	1.6k 1.9×	1.0k 1.8×	793 1.6×	83	4.2k
Elise S. van Haastert Netherlands	27	534 0.6×	1.2k 1.4×	1.3k 1.5×	548 1.0×	600 1.2×	31	3.3k
Annick Mouatt‐Prigent France	17	1.6k 1.8×	1.3k 1.5×	583 0.7×	1.4k 2.6×	506 1.0×	20	3.3k
Yungui Zhou United States	22	404 0.5×	1.5k 1.7×	2.2k 2.6×	706 1.3×	483 1.0×	29	4.3k
Teng‐Nan Lin Taiwan	28	307 0.3×	1.4k 1.7×	394 0.5×	583 1.1×	344 0.7×	62	3.0k
Wencheng Liu Taiwan	12	1.0k 1.2×	1.2k 1.4×	627 0.7×	534 1.0×	967 2.0×	32	2.5k
Barry Boland Ireland	18	396 0.4×	1.2k 1.4×	1.5k 1.8×	416 0.8×	1.1k 2.2×	26	3.0k
Shavali Shaik United States	30	421 0.5×	2.2k 2.6×	277 0.3×	381 0.7×	280 0.6×	43	3.2k
Brent J. Ryan United Kingdom	24	1.0k 1.2×	1.1k 1.2×	601 0.7×	660 1.2×	418 0.9×	35	2.4k
Jordi Magrané United States	27	1.4k 1.6×	2.2k 2.5×	1.0k 1.2×	781 1.4×	1.1k 2.3×	36	3.9k

Countries citing papers authored by Michaeline Hebron

Since Specialization

Citations

This map shows the geographic impact of Michaeline Hebron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaeline Hebron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaeline Hebron more than expected).

Fields of papers citing papers by Michaeline Hebron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaeline Hebron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaeline Hebron. The network helps show where Michaeline Hebron may publish in the future.

Co-authorship network of co-authors of Michaeline Hebron

This figure shows the co-authorship network connecting the top 25 collaborators of Michaeline Hebron. A scholar is included among the top collaborators of Michaeline Hebron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaeline Hebron. Michaeline Hebron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hebron, Michaeline, et al.. (2024). c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease. Life Science Alliance. 7(10). e202402625–e202402625. 4 indexed citations

Liu, Xiaoguang, Kaluvu Balaraman, Ciarán C. Lynch, et al.. (2022). Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice. International Journal of Molecular Sciences. 23(15). 8131–8131. 8 indexed citations

Bacik, J.P., Ruilian Wu, Ramesh K. Jha, et al.. (2022). Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase. PLoS ONE. 17(11). e0277670–e0277670. 4 indexed citations

Liu, Xiaoguang, Kaluvu Balaraman, Ciarán C. Lynch, et al.. (2021). Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology. Metabolites. 11(9). 622–622. 18 indexed citations

Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, Jaeil Ahn, & Charbel Moussa. (2021). Long-term Safety and Clinical Effects of Nilotinib in Parkinson’s Disease (4799). Neurology. 96(15_supplement). 1 indexed citations

Fowler, Alan J., Michaeline Hebron, Yasar Torres‐Yaghi, et al.. (2020). A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration (5398). Neurology. 94(15_supplement). 1 indexed citations

Hebron, Michaeline, et al.. (2018). Tau clearance improves astrocytic function and brain glutamate-glutamine cycle. Journal of the Neurological Sciences. 391. 90–99. 38 indexed citations

Moussa, Charbel, Michaeline Hebron, Xu Huang, et al.. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. Journal of Neuroinflammation. 14(1). 1–1. 568 indexed citations breakdown →

Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2016). Nilotinib Improves Motor Skills, Cognition and Autonomic Function in Open-Label Phase I Clinical Trial in Parkinsons Disease with Dementia and Lewy Body Dementia (I1.008). Neurology. 86(16_supplement). 1 indexed citations

10.

Hebron, Michaeline, Jacqueline Smith, Charisse N. Winston, et al.. (2016). Tyrosine kinase inhibition reverses TDP‐43 effects on synaptic protein expression, astrocytic function and amino acid dis‐homeostasis. Journal of Neurochemistry. 139(4). 610–623. 35 indexed citations

11.

Pagán, Fernando, Michaeline Hebron, Yasar Torres‐Yaghi, et al.. (2016). Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies. Journal of Parkinson s Disease. 6(3). 503–517. 193 indexed citations

12.

Moussa, Charbel & Michaeline Hebron. (2015). Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration. SHILAP Revista de lepidopterología. 10(11). 1767–1767. 5 indexed citations

13.

Hebron, Michaeline. (2014). Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy. Journal of Clinical & Cellular Immunology. 5(5). 259–259. 48 indexed citations

14.

Chen, Wenqiang, Irina Lonskaya, Michaeline Hebron, et al.. (2014). Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Human Molecular Genetics. 23(18). 4960–4969. 33 indexed citations

15.

Lonskaya, Irina, Michaeline Hebron, Wenqiang Chen, Joel B. Schachter, & Charbel Moussa. (2014). Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models. Molecular Neurodegeneration. 9(1). 46–46. 35 indexed citations

16.

Hebron, Michaeline, Norah K. Algarzae, Irina Lonskaya, & Charbel Moussa. (2013). Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and Aβ1-42 gene transfer models. Experimental Neurology. 251. 127–138. 13 indexed citations

17.

Lonskaya, Irina, et al.. (2013). Tyrosine kinase inhibition increases functional parkin‐ B eclin‐1 interaction and enhances amyloid clearance and cognitive performance. EMBO Molecular Medicine. 5(8). 1247–1262. 114 indexed citations

18.

Hebron, Michaeline, Irina Lonskaya, & Charbel Moussa. (2013). Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models. Human Molecular Genetics. 22(16). 3315–3328. 249 indexed citations

19.

Lonskaya, Irina, et al.. (2012). Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson’s disease. Neuroscience. 232. 90–105. 56 indexed citations

20.

Hebron, Michaeline, et al.. (2012). Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6). Journal of Biological Chemistry. 288(6). 4103–4115. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact